ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Encoded Therapeutics
The Associate Director, Global Publications plays a key role within the Medical and Patient Affairs team, supporting the strategy, development, and execution of global scientific publication plans. This role oversees the translation of complex clinical, translational, and non-clinical data into high-impact manuscripts, abstracts, posters, and congress presentations. The position reports to the Director, Scientific Communications.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2014
Encoded Therapeutics is a biotechnology company focused on translating next-generation science into transformative gene therapies for neurological disorders. The company's novel targeting and regulation platform is designed to overcome first-generation gene therapy challenges by enabling greater gene specificity, cell selectivity, and potency. Encoded's lead program, ETX101, is currently in pivotal clinical development for Dravet Syndrome, with a broader precision genetic medicines neurology pipeline underway.
Business WireEncoded Therapeutics Presents Positive Interim Efficacy Data from Initial Dose Levels of Phase 1/2 Trials Evaluating ETX101 Gene Therapy in Dravet Syndrome
Dec 5, 2025
Fierce BiotechEncoded deciphers path to pivotal trial with phase 1/2 Dravet gene therapy data
Dec 5, 2025
www.bioworld.comPhase III update Stokes hope; Dravet game-change Encoded?
Jan 12, 2026
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Encoded Therapeutics.
Business WireEncoded Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome
Jan 12, 2026
Director, Scientific Publications
Celldex Therapeutics
Senior Publications Manager, Oncology
AbbVie
Senior Manager, Scientific Publications
Corcept Therapeutics
Medical Writer (Publications)
lifelancer
Publication Specialist, Project Management - Hybrid
MSD
Senior Manager, Global Scientific Communications
AstraZeneca
